148 related articles for article (PubMed ID: 33172922)
1. Frequency and prediction of deep uterine involvement in advanced high-grade epithelial ovarian cancer: is uterine preservation an option?
Perri T; Harel G; Dadon T; Mor-Sasson A; Yagel I; Ben-Baruch G; Korach J
Int J Gynecol Cancer; 2021 Feb; 31(2):251-256. PubMed ID: 33172922
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of uterine involvement in low grade serous ovarian carcinoma.
Petiot F; Descargues P; Devouassoux-Shisheboran M; You B; Rousset-Jablonski C; Raffin D; Hajri T; Gertych W; Glehen O; Philip CA; Lamblin G; Golfier F; Bolze PA
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():191-197. PubMed ID: 38295707
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma.
Nasioudis D; Mulugeta-Gordon L; McMinn E; Byrne M; Ko EM; Cory L; Haggerty AF; Latif NA
Int J Gynecol Cancer; 2021 Mar; 31(3):480-483. PubMed ID: 33649017
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
5. Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Morgan MA; Ko EM; Latif NA
Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():63-70. PubMed ID: 32182501
[TBL] [Abstract][Full Text] [Related]
6. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
7. Is hysterectomy needed in ovarian cancer?
Chitrathara K; Sheikh ZA; Vijaykumar DK; Kuriakose S; Anupama R; Nandeesh M
Indian J Cancer; 2011; 48(4):471-6. PubMed ID: 22293263
[TBL] [Abstract][Full Text] [Related]
8. Uterine involvement in epithelial ovarian cancer and its risk factors.
Zamani N; Mousavi AS; Akhavan S; Sheikhhasani S; Nikfar S; Feizabad E; Rezayof E; Modares Gilani M
J Ovarian Res; 2021 Dec; 14(1):171. PubMed ID: 34876191
[TBL] [Abstract][Full Text] [Related]
9. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
10. Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.
Kohn JR; Katebi Kashi P; Acosta-Torres S; Beavis AL; Christianson MS
J Minim Invasive Gynecol; 2021 Mar; 28(3):392-402. PubMed ID: 33373729
[TBL] [Abstract][Full Text] [Related]
11. Could uterine conservation be an option in presumed early-stage epithelial ovarian cancer?
Benoit L; Pajot C; Koual M; Nguyen-Xuan HT; Bentivegna E; Bats AS; Azaïs H
Arch Gynecol Obstet; 2023 Sep; 308(3):953-960. PubMed ID: 37031304
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer.
Muallem MZ; Sehouli J; Richter R; Babayeva A; Gasimli K; Parashkevova A
Int J Gynecol Cancer; 2020 Jan; 30(1):62-66. PubMed ID: 31744887
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
[TBL] [Abstract][Full Text] [Related]
14. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
[TBL] [Abstract][Full Text] [Related]
16. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
17. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up.
Gallotta V; Jeong SY; Conte C; Trozzi R; Cappuccio S; Moroni R; Ferrandina G; Scambia G; Kim TJ; Fagotti A
Eur J Surg Oncol; 2021 Jul; 47(7):1698-1704. PubMed ID: 33573854
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
Lof P; van de Vrie R; Korse CM; van Driel WJ; van Gent MDJM; Karlsen MA; Amant F; Lok CAR
Int J Gynecol Cancer; 2019 Oct; 29(8):1304-1310. PubMed ID: 31515411
[TBL] [Abstract][Full Text] [Related]
20. Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.
Sørensen SM; Schnack TH; Høgdall C
Acta Obstet Gynecol Scand; 2019 Jan; 98(1):34-43. PubMed ID: 30168853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
